What does Nova In Silico do?

Nova In Silico has built jinkō, a unique in silico clinical trial simulation platform designed to de-risk and accelerate clinical trials.

How many employees does Nova In Silico have?

Nova In Silico has approximately 56 employees.

What industry is Nova In Silico in?

Nova In Silico operates in Biotechnology / Clinical Trial Software.

Is Nova In Silico still active?

Yes, Nova In Silico was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.

How do I sell to Nova In Silico?

Research Nova In Silico's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details.

Data Surfer

How it works Insights Pricing FAQ Contact Login

Nova In Silico

Biotechnology / Clinical Trial Software

56 employees

novainsilico.ai

Verified active February 2, 2026

Key Highlights

Founded in 2010, Nova In Silico is a software development company.
Specializes in advanced clinical trial simulation software.
The Jinkō® platform de-risks and accelerates R&D.
Empowers biotech, pharma, and academic research institutions.
Employs a dedicated team of 56 professionals.

About Nova In Silico

Nova In Silico offers the Jinkō® platform, a sophisticated clinical trial simulation solution designed to revolutionize drug research and development. This innovative software leverages advanced modeling and simulation techniques to de-risk and accelerate the creation of new therapies, ultimately benefiting patients by bringing effective treatments to market faster. The Jinkō® platform serves a diverse clientele, including biotech and pharmaceutical companies, academic research centers, and non-profit organizations. It empowers these entities to identify patient populations most likely to respond to treatments, optimize drug regimens, generate synthetic control arms for trials, and explore research scenarios that are often impractical or impossible with traditional methods.

Company Facts

Ownership Private Company

Technology Stack

artificial intelligence
data science
applied mathematics

Why Contact Nova In Silico?

Nova In Silico's Jinkō® platform accelerates therapeutic R&D by enabling predictive clinical trial simulations, optimizing drug development, and generating synthetic control arms, leading to more successful and efficient drug discovery.

Who Should Contact Nova In Silico for Business?

Biotech and pharmaceutical companies, academic research centers, and non-profit organizations seeking to de-risk and accelerate their drug development pipelines.

Frequently Asked Questions

What does Nova In Silico do?: Nova In Silico has built jinkō, a unique in silico clinical trial simulation platform designed to de-risk and accelerate clinical trials.
How many employees does Nova In Silico have?: Nova In Silico has approximately 56 employees.
What industry is Nova In Silico in?: Nova In Silico operates in Biotechnology / Clinical Trial Software.
Is Nova In Silico still active?: Yes, Nova In Silico was verified as an active company on February 2, 2026. Data Surfer regularly validates company information to ensure accuracy.
How do I sell to Nova In Silico?: Research Nova In Silico's priorities and goals, identify the right decision makers and champions, monitor for buying signals, and reach out at the right time with verified contact details. Learn how Data Surfer helps.